Enveric Biosciences Chairman David Johnson's 2021 pay rises 9% to $6.9M
Enveric Biosciences reports 2021 executive compensation
By ExecPay News
Published: September 23, 2022
Enveric Biosciences reported fiscal year 2021 executive compensation information on September 23, 2022.
In 2021, five executives at Enveric Biosciences received on average a compensation package of $3.4M, a 2,521% increase compared to previous year.
Average pay of disclosed executives at Enveric Biosciences
David Johnson, Chairman, received $6.9M in total, which increased by 3,344% compared to 2020. 94% of Johnson's compensation, or $6.5M, was in stock awards. Johnson also received $169K in bonus and $250K in salary.
Avani Kanubaddi, Chief Operating Officer, received a compensation package of $4.2M, which increased by 6961% compared to previous year. 89% of the compensation package, or $3.8M, was in stock awards.
Joseph Tucker, Chief Executive Officer, earned $2.5M in 2021.
Robert Wilkins, Chief Medical Officer, received $1.7M in 2021.
Peter Facchini, Chief Innovation Officer, earned $1.7M in 2021.
Related executives
You may also like
Source: SEC filing on September 23, 2022.